Dayne Brown

Associate

+1 212 479 6712
dayne.brown@cooley.com

Dayne Brown has a broad corporate practice. She counsels technology and life sciences companies on transactions from formation through exit.

Download full bio

Experience

  • Prevail Therapeutics $125 Million IPO 

  • Gamida Cell – $50 Million IPO 

  • MeiraGTx – $75 Million IPO 

  • Zealand Pharma – $89 Million IPO 

Education

  • University of Chicago
    JD, 2014

  • University of Washington
    BA, English Literature & International Studies
    2005


Admissions & Credentials

New York

Washington

Media & Insight

Contact

+1 212 479 6712 office
dayne.brown@cooley.com

55 Hudson Yards
New York, NY 10001-2157